Status:
WITHDRAWN
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
Lead Sponsor:
University of California, San Diego
Conditions:
Major Fetal Anomaly
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To gain knowledge about how patients undergoing prenatal diagnosis for a fetal abnormality understand and react to Whole Genome Sequencing (WGS) testing, so that the investigators can develop more eth...
Detailed Description
Although whole exome sequencing (WES) was first used for identification of the genetic cause of a disease only in 2009 and whole genome sequencing (WGS) in 2010, and questions remain about their perfo...
Eligibility Criteria
Inclusion
- Subject(s) 18 years or older (both mom and father of baby (FOB)
- Subject is undergoing prenatal testing for a major fetal anomaly
Exclusion
- Mothers or fathers of the affected fetus are under the age of 18 years
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02255825
Start Date
October 1 2014
End Date
June 4 2019
Last Update
June 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSD Health Sciences, Fetal Care and Genetics
San Diego, California, United States, 92121